
Example 1: skin and aesthetic care
Ongoing care for skin firmness and radiance alongside overall health maintenance.

Particle count per 2mL vial2.62 trillion particlesView analysis data
See how collection, cell culture, treatment contents and quality checks differ
We bring together whole-body IV treatment, local treatment and testing to track changes over time. Your doctor works with you to plan care around your health and goals.
Whole-body
wellbeing
Skin and
aesthetic care
Joint health and mobility
wellbeing
Regenerative medicine
options
A healthier future, from within.

Whole-body care
After discussing your overall health and treatment goals,
exosomes are given by intravenous infusion.
The treatment plan considers more than one area,
taking your overall health into account.
Exosomes
circulate throughout the body
Supporting whole-body
wellbeing
Through ongoing testing,
monitor changes
A 12-session plan: IV + local treatment + testing
The 12-session plan combines whole-body IV treatment, a choice of local treatment and testing to monitor your progress.
At each visit, you and your doctor choose the local treatment area based on your needs and condition.



Discuss with your doctor which area is most suitable for your condition and goals at that visit.







Other areas may also be considered following a doctor's examination.
The combination can be adjusted to your condition at every visit.

Ongoing care for skin firmness and radiance alongside overall health maintenance.

Supporting recovery in areas of concern while considering overall physical condition.

Addressing painful areas alongside overall health maintenance.
Treatment and testing at each visit help monitor changes and inform the next treatment.
Systemic + local administration
(select an area)
Systemic + local administration
(select an area)
Systemic + local administration
(select an area)
Systemic + local administration
(select an area)
Plan future care
Testing over time helps you and your doctor see what is changing.

Why exosomes?
At AKASAKA g-lab Clinic, treatment is planned while continually reviewing your condition.
We select exosome therapy to reduce the harvesting, culture and waiting steps.

Stem cells are collected from your own fat,
then cultured before administration.

An analyzed exosome preparation is used,
with administration planned for your condition.
A procedure is required to collect fat.
There is no physical burden from fat collection.
The collected cells are grown in culture to increase their number.
We use a preparation that has already been manufactured and analyzed.
From collection to administration, several weeks to several months may be needed.
There is no waiting for harvesting or culture.
Stem cell characteristics vary with age, health and lifestyle.
We use preparations manufactured and analyzed against defined standards.
The administered cells are harvested and cultured from your own body.
Living cells themselves are not administered.
Storage, culture and administration schedules are planned in advance.
It can be incorporated into a 12-session program, with treatment considered at appropriate times.
Analysis and verification methods differ by treatment and facility.
miRNA and IPA analyses are used to examine preparation characteristics.
We seek better options based on findings from research.
Discuss with your doctor and choose a plan suited to your goals and condition.
We consider both your health today and your needs in the years ahead.
What can testing tell you?
Blood miRNA analysis examines your current condition and changes in the internal environment associated with cancer.
We follow changes over time, comparing with your previous results rather than relying on one result.
We review current physical condition through indicators of cellular health.
Are your cells and tissues maintaining healthy, stable function?
Are low oxygen levels or oxidative stress putting strain on cells?
Is inflammation continuing even without noticeable symptoms?
Are there changes linked to stiffening or fibrosis in the skin, blood vessels, organs or bones?

We examine changes associated with an environment in which cancer may grow.
(This is not a test to diagnose cancer.)
Is the ability to prevent excessive cell growth maintained?
Are there changes in blood vessels, oxygen supply or surrounding tissues associated with cancer growth?
Are signals associated with cell proliferation and activity becoming stronger?
Are there signs of increasing tissue stiffness or fibrosis?
Establish a baseline of your current health.
Compare with previous results to identify small changes.
Accumulated data help assess treatment and lifestyle effects as a whole.
The research behind the testing
Professor Takahiro Ochiya has long led research into exosomes and miRNA.
g-lab uses Theoria testing developed from that research for ongoing health management.

A long-standing leader in exosome and miRNA research
Theoria Science Founder / CSO
Specially Appointed Professor at Tokyo Medical University

Recognized by researchers around the world
Exosome research
Ranked among the world's leaders through expert analysis
Exosome research
Ranked among the world's leaders for long-term research achievements
Highly Cited Researchers
Recognized as a Highly Cited Researcher
Findings from many years of exosome and miRNA research.
Research-based testing to help assess your current health.
Regular testing helps follow changes and informs health management.
g-lab also analyzes the exosome preparation itself before administration.
(Analysis of the genetic information in the preparation)
(Analysis of functions and pathways)
Looking at both your health and the preparation through a scientific lens.
So you can make a more informed choice.

What is in the exosome preparation?
How much is present matters.
So do the contents and their balance.
2.62 trillion

Per vial
2.62 × 1012 particles

Tumor Suppressor
miRNA
Associated with tumor suppression
miRNA 88%
OncomiR (oncogenic classification) 12%
Are sufficient particles present?
Which miRNAs are present?
Review miRNA composition across the preparation
Use IPA to explore associations with biological pathways
Detected miRNAs are compared with literature and databases,
to explore the bodily functions they have been linked to in published research.
Inflammation
Immunity
Blood vessels
Nerves
Cell repair
Reproductive function
Hormones
Cancer-related pathways
IPA explores associated biological functions; it does not guarantee treatment effectiveness or safety.
View the analysis materials underlying the information on this page.
Your health and the treatment you receive both matter.
Our doctors consider both when planning your care.
Model W / Model P
Review current physical condition
Particle count / miRNA / IPA
Examine the administered preparation
The doctor considers both sets of information
to plan treatment
Understand the proposed care, suitability and practical arrangements before booking your trip. A visit to Japan gives you the opportunity to discuss testing and a continuing care plan directly with the clinic.
Request a consultation about your goals, medical background and preferred travel dates. Interpreter availability and scope must be confirmed in advance.
Discuss visit intervals and the length of stay with the clinic. A short stay may not accommodate a full program; a return-visit plan may be needed.
Request an individual estimate for consultation, testing and treatment. Flights and hotels are separate. Confirm interpreter fees and cancellation terms before making arrangements.
No. The clinic will contact you to discuss availability and confirm the appointment.
Whether the full program can be completed in one trip depends on your medical assessment and the agreed time between sessions. Please discuss your travel plans with the clinic before booking.
Flights and hotels are separate. Ask the clinic to confirm interpreter support, arrangements and any additional fees before you travel.
This is self-pay care. Ask for the proposed treatment details and an itemized estimate. Discuss risks, side effects, approval status and the evidence for the specific preparation before deciding.
Request a consultation →Discuss a treatment plan with your doctor after reviewing your condition and goals.
This treatment is privately funded. During your consultation, discuss suitability, costs, risks and side effects, and the approval status of the preparation. Results vary from person to person; this page does not guarantee treatment outcomes.
Particle count is calculated per 2mL vial from a measured concentration of 1.31×10¹² particles/mL. The miRNA percentages are normalized by expression level within the classified subset of the top-100 miRNAs. This subset accounts for about 53% of the total and includes miRNAs whose tumor-suppressing or tumor-promoting roles have been reported in the literature. miRNAs with conflicting reports or without an established classification are excluded. These results apply only to the analyzed lot, not to every preparation or lot.
Reviewed by Dr. Tomokazu Gima, Director, AKASAKA g-lab CLINIC (Neurosurgery / Regenerative Medicine). 5 October 2026.
Treatment and fee information →